Depressive symptoms and schizophrenic relapses

The effect of four neuroleptic drugs

Massimo C. Mauri, Antonella Bitetto, Lorenza Fabiano, Valerio Laini, Clara Steinhilber, Monica Fornier, Farouk Rafique

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

1. A prevalence of depressive symptomatology, ranging from 25% to 80% has been reported during the course of schizophrenia. 2. Depressive symptoms were assessed in 144 schizophrenic patients (DSM IV) during an acute exacerbation phase. 3. Depressive symptoms showed a prevalence ranging from 5.5% (severe clinical pictures) to 54.8 % (mild clinical pictures). 4. The authors did not find a correlation between depressive symptoms per se and the presence of negative psychotic symptoms. Depression may be linked not so much to negative symptoms but to the psychotic state itself. 5. Depressive symptomatology concurrently occured with schizophrenic relapses and improved together with the psychotic clinical picture, independently of the neuroleptic drug employed. Haloperidol, haloperidol decanoate and fluphenazine decanoate all showed a similar improvement of depressive symptoms. 6. L-sulpiride showed a trend to be most effective on depressive symptomatology in comparison to the other neuroleptics.

Original languageEnglish
Pages (from-to)43-54
Number of pages12
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume23
Issue number1
DOIs
Publication statusPublished - Jan 1999

Fingerprint

Antipsychotic Agents
Depression
Recurrence
Sulpiride
Haloperidol
Diagnostic and Statistical Manual of Mental Disorders
Schizophrenia

Keywords

  • Depression
  • Negative symptoms
  • Neuroleptic treatment
  • Schizophrenia

ASJC Scopus subject areas

  • Biological Psychiatry
  • Pharmacology

Cite this

Depressive symptoms and schizophrenic relapses : The effect of four neuroleptic drugs. / Mauri, Massimo C.; Bitetto, Antonella; Fabiano, Lorenza; Laini, Valerio; Steinhilber, Clara; Fornier, Monica; Rafique, Farouk.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 23, No. 1, 01.1999, p. 43-54.

Research output: Contribution to journalArticle

Mauri, Massimo C. ; Bitetto, Antonella ; Fabiano, Lorenza ; Laini, Valerio ; Steinhilber, Clara ; Fornier, Monica ; Rafique, Farouk. / Depressive symptoms and schizophrenic relapses : The effect of four neuroleptic drugs. In: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 1999 ; Vol. 23, No. 1. pp. 43-54.
@article{0bc35abc54534c3daafdf47ed18d2dba,
title = "Depressive symptoms and schizophrenic relapses: The effect of four neuroleptic drugs",
abstract = "1. A prevalence of depressive symptomatology, ranging from 25{\%} to 80{\%} has been reported during the course of schizophrenia. 2. Depressive symptoms were assessed in 144 schizophrenic patients (DSM IV) during an acute exacerbation phase. 3. Depressive symptoms showed a prevalence ranging from 5.5{\%} (severe clinical pictures) to 54.8 {\%} (mild clinical pictures). 4. The authors did not find a correlation between depressive symptoms per se and the presence of negative psychotic symptoms. Depression may be linked not so much to negative symptoms but to the psychotic state itself. 5. Depressive symptomatology concurrently occured with schizophrenic relapses and improved together with the psychotic clinical picture, independently of the neuroleptic drug employed. Haloperidol, haloperidol decanoate and fluphenazine decanoate all showed a similar improvement of depressive symptoms. 6. L-sulpiride showed a trend to be most effective on depressive symptomatology in comparison to the other neuroleptics.",
keywords = "Depression, Negative symptoms, Neuroleptic treatment, Schizophrenia",
author = "Mauri, {Massimo C.} and Antonella Bitetto and Lorenza Fabiano and Valerio Laini and Clara Steinhilber and Monica Fornier and Farouk Rafique",
year = "1999",
month = "1",
doi = "10.1016/S0278-5846(98)00090-6",
language = "English",
volume = "23",
pages = "43--54",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Depressive symptoms and schizophrenic relapses

T2 - The effect of four neuroleptic drugs

AU - Mauri, Massimo C.

AU - Bitetto, Antonella

AU - Fabiano, Lorenza

AU - Laini, Valerio

AU - Steinhilber, Clara

AU - Fornier, Monica

AU - Rafique, Farouk

PY - 1999/1

Y1 - 1999/1

N2 - 1. A prevalence of depressive symptomatology, ranging from 25% to 80% has been reported during the course of schizophrenia. 2. Depressive symptoms were assessed in 144 schizophrenic patients (DSM IV) during an acute exacerbation phase. 3. Depressive symptoms showed a prevalence ranging from 5.5% (severe clinical pictures) to 54.8 % (mild clinical pictures). 4. The authors did not find a correlation between depressive symptoms per se and the presence of negative psychotic symptoms. Depression may be linked not so much to negative symptoms but to the psychotic state itself. 5. Depressive symptomatology concurrently occured with schizophrenic relapses and improved together with the psychotic clinical picture, independently of the neuroleptic drug employed. Haloperidol, haloperidol decanoate and fluphenazine decanoate all showed a similar improvement of depressive symptoms. 6. L-sulpiride showed a trend to be most effective on depressive symptomatology in comparison to the other neuroleptics.

AB - 1. A prevalence of depressive symptomatology, ranging from 25% to 80% has been reported during the course of schizophrenia. 2. Depressive symptoms were assessed in 144 schizophrenic patients (DSM IV) during an acute exacerbation phase. 3. Depressive symptoms showed a prevalence ranging from 5.5% (severe clinical pictures) to 54.8 % (mild clinical pictures). 4. The authors did not find a correlation between depressive symptoms per se and the presence of negative psychotic symptoms. Depression may be linked not so much to negative symptoms but to the psychotic state itself. 5. Depressive symptomatology concurrently occured with schizophrenic relapses and improved together with the psychotic clinical picture, independently of the neuroleptic drug employed. Haloperidol, haloperidol decanoate and fluphenazine decanoate all showed a similar improvement of depressive symptoms. 6. L-sulpiride showed a trend to be most effective on depressive symptomatology in comparison to the other neuroleptics.

KW - Depression

KW - Negative symptoms

KW - Neuroleptic treatment

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=0032980211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032980211&partnerID=8YFLogxK

U2 - 10.1016/S0278-5846(98)00090-6

DO - 10.1016/S0278-5846(98)00090-6

M3 - Article

VL - 23

SP - 43

EP - 54

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

IS - 1

ER -